Other clinical characteristics (white blood cell (WBC) count, hemoglobin, peripheral blood and bone marrow blasts, t-AML, and AML secondary to MDS/MPN) were not associated with RUNX1 mutational status. Here, RUNX1 is linked to myelodysplastic syndrome.